Your browser doesn't support javascript.
loading
Country uptake of WHO recommendations on differentiated HIV testing services approaches: a global policy review.
Kadye, Tafadzwa; Jamil, Muhammad S; Johnson, Cheryl; Baggaley, Rachel; Barr-DiChiara, Magdalena; Cambiano, Valentina.
Affiliation
  • Kadye T; Global Health, UCL, London, UK tafkadye@gmail.com.
  • Jamil MS; World Health Organization, Geneva, Switzerland.
  • Johnson C; Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.
  • Baggaley R; World Health Organization, Geneva, Switzerland.
  • Barr-DiChiara M; Department of Global Programmes of HIV, Hepatitis and HIV, World Health Organization, Geneva, Switzerland.
  • Cambiano V; UCL, London, UK.
BMJ Open ; 14(3): e058098, 2024 Mar 13.
Article in En | MEDLINE | ID: mdl-38485173
ABSTRACT

OBJECTIVES:

In 2015 and 2016, WHO issued guidelines on HIV testing services (HTS) highlighting recommendations for a strategic mix of differentiated HTS approaches. The policy review examines the uptake of differentiated HTS approaches recommendations in national policies.

METHODS:

Data were extracted from national policies published between January 2015 and June 2019. The WHO-recommended HTS approaches included facility-based testing, community-based testing, HIV self-testing and provider-assisted referral (or assisted partner notification). Other supportive recommendations include pre-test information, post-test counselling, lay provider testing and rapid testing. Descriptive analyses were conducted to examine inclusion of recommendations in national policies.

RESULTS:

Of 194 countries worldwide, 65 published policies were identified; 24 WHO Africa region (AFR) countries (51%, 24/47), 21 WHO European region (EUR) (40%, 21/53), 6 WHO Eastern Mediterranean region (EMR) (29%, 6/21), 5 Pan-American region (AMR) (14%, 5/35), 5 Western Pacific Region (WPR) (19%, 5/27) and 4 WHO South East Asia Region (SEAR) (36%, 4/11). Only five countries included all recommendations. 63 included a minimum of one. 85% (n=55) included facility-based testing for pregnant women, 75% (n=49) facility-based testing for key populations, 74% (n=48) community-based testing for key populations, 69% (n=45) rapid testing, 57% (n=37) post-test counselling, 45% (n=29) lay provider testing, 38% (n=25) HIV self-testing, 29% (n=19) pre-test information and 25% (n=16) provider-assisted referral. The proportion in each region that included at least one recommendation were 100% AFR (24/47), 100% EMR (6/6), 100% AMR (5/5), 100% WPR (5/5), 100% SEAR (4/4) and 95% EUR (20/21). AFR followed by EMR included the highest number of reccomendations.

CONCLUSION:

There was substantial variability in the uptake of the WHO-differentiated HTS recommendations. Those in EMR included the most WHO-differentiated HTS recommendation followed by AFR. Countries within AMR included the least number of recommendations. Ongoing advocacy and efforts are needed to support the uptake of the WHO-differentiated HTS recommendations in country policies as well as their implementation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV Testing Limits: Female / Humans / Pregnancy Language: En Journal: BMJ Open Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV Testing Limits: Female / Humans / Pregnancy Language: En Journal: BMJ Open Year: 2024 Document type: Article Country of publication: